Anteris Technologies Global Corp.
IPORevolutionizing the heart valve replacement market | Anteris Technologies
- Headquarters
- Eagan, Minnesota
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Website
- anteristech.com
- Total Funding
- $344.1M
- Last Round
- $320.0M Growth EquityJan 2025
- Rounds
- 2
- Type
- Public
About
Anteris Technologies is a global structural heart company founded in 2006 and headquartered in Eagan, Minnesota, focused on developing transcatheter heart valve solutions. Its flagship product, the DurAVR® Transcatheter Heart Valve, is a first-in-class biomimetic single-piece valve built from ADAPT® anti-calcification tissue designed to restore healthy aortic blood flow patterns. The company is publicly traded on both Nasdaq and the ASX, with operations across the United States, Europe, and Australia, and received a strategic $90 million investment from Medtronic.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...